Table 4.
Therapeutic modalities applied and outcomes of patients with Dengue Shock Syndrome receiving intensive care.
Therapies | Deaths | Discharges | Total | χ 2 | .df | P | |
---|---|---|---|---|---|---|---|
Inotropes | Yes | 15 | 12 | 27 | 17.41 | 1 | <0.001 |
No | 01 | 26 | 27 | ||||
Total | 16 | 38 | 54 | ||||
| |||||||
Mechanical ventilation | Yes | 15 | 4 | 19 | 34.1 | 1 | <0.001 |
No | 1 | 34 | 35 | ||||
Total | 16 | 38 | 54 | ||||
| |||||||
Liver failure regime | Yes | 9 | 3 | 12 | 15.23 | 1 | <0.001 |
No | 7 | 35 | 42 | ||||
Total | 16 | 38 | 54 | ||||
| |||||||
Peritoneal dialysis | Yes | 8 | 0 | 8 | 22.3 | 1 | <0.001 |
No | 8 | 38 | 46 | ||||
Total | 16 | 38 | 54 | ||||
| |||||||
Blood products | 1 | 14 | 11 | 25 | 15.2 | 1 | < 0.001 |
2 | 2 | 27 | 29 | ||||
Total | 16 | 38 | 54 | ||||
| |||||||
Steroids | Yes | 7 | 13 | 20 | 0.353 | 1 | 0.553 |
No | 9 | 24 | 33 | ||||
Total | 16 | 37 | 53 |